Agilent Pursuit 3 C8 150 x 4.6mm A3031150X046
Pursuit 200Å C8, 4.6 x 150 mm, 3 µm. Ideal columns for LC/MS in pharmaceuticals, from drug discovery analysis to QC processes, ensuring effective evaluation of raw materials and drugs.
Key Features:
- Phase: C8
- Dimensions: 150 x 4.6 mm
- Particle size: 3 µm
- Pore size: 200 Å
- Pressure rating: 400 bar
- pH range: 2–8
Advantages:
- Specified by the manufacturer as ideal for LC/MS in pharmaceutical workflows, supporting applications from drug discovery to quality control.
- Designed to ensure effective evaluation of raw materials and drugs, per the official product description.
- 3 µm fully porous particles combined with a 200 Å pore structure and 400 bar pressure rating enable high-efficiency reversed-phase separations for small to medium molecular weight analytes.
Product Details
Overview
| Model | |
|---|---|
| Product Type | Consumables |
| Part Number | A3031150X046 |
| Brand | Agilent Technologies |
| Gross Dimensions (WxDxH cm) | |
| Net Dimensions (WxDxH cm) | |
| Gross Weight (kg) | |
| Net Weight (kg) |
Specifications
| Separation Mode | Reversed Phase |
|---|---|
| Particle Size | 3 µm |
| Length | 150 mm |
| Inner Diameter | 4.6 mm |
Document
Videos
Agilent Technologies
Agilent supports scientists in 110 countries in cutting-edge life science research; patient diagnostics; and testing required to ensure the safety of water, food and pharmaceuticals. Their advanced instruments, software, consumables, and services enable customers to produce the most accurate and reliable results as well as optimal scientific, economic, and operational outcomes.
Agilent plays a role in advancing important research and testing, with their scientists creating some of the world's most leading-edge technology and their field engineers working side by side with customers to help them maximize productivity. Agilent bring these solutions to a variety of markets, from pharma and diagnostics to applied materials and chemicals.
Together with customers, Agilent is bringing great science to life.